2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the, ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) ,
Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9 ,
DOI : 10.1164/rccm.200510-1668OC
Mutation in the Gene for Bone Morphogenetic Protein Receptor II as a Cause of Primary Pulmonary Hypertension in a Large Kindred, New England Journal of Medicine, vol.345, issue.5, pp.319-343, 2001. ,
DOI : 10.1056/NEJM200108023450502
Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia, New England Journal of Medicine, vol.345, issue.5, pp.325-359, 2001. ,
DOI : 10.1056/NEJM200108023450503
A Novel Channelopathy in Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.369, issue.4, pp.351-61, 2013. ,
DOI : 10.1056/NEJMoa1211097
Whole Exome Sequencing to Identify a Novel Gene (Caveolin-1) Associated With Human Pulmonary Arterial Hypertension, Circulation: Cardiovascular Genetics, vol.5, issue.3, pp.336-379, 2012. ,
DOI : 10.1161/CIRCGENETICS.111.961888
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation ,
) Mutation, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.8, pp.851-61, 2010. ,
DOI : 10.1164/rccm.200908-1284OC
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis, The Lancet Respiratory Medicine, vol.4, issue.2, pp.129-166, 2014. ,
DOI : 10.1016/S2213-2600(15)00544-5
URL : http://doi.org/10.1016/s2213-2600(15)00544-5
mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies, Clinical Genetics, vol.270, issue.6, pp.579-83, 2015. ,
DOI : 10.1111/cge.12549
EIF2AK4 Mutations in Pulmonary Capillary Hemangiomatosis, Chest, vol.145, issue.2, pp.231-267, 2014. ,
DOI : 10.1378/chest.13-2366
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921094
Pulmonary veno-occlusive disease, European Respiratory Journal, vol.47, issue.5, pp.1518-1552, 2016. ,
DOI : 10.1183/13993003.00026-2016
URL : https://hal.archives-ouvertes.fr/inserm-01436297
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease, European Respiratory Journal, vol.46, issue.6, pp.1721-1752, 2015. ,
DOI : 10.1183/13993003.00814-2015
Chemotherapy-induced pulmonary hypertension: Role of alkylating agents, European Respiratory Journal, vol.46, issue.suppl 59, pp.356-71, 2015. ,
DOI : 10.1183/13993003.congress-2015.PA581
Mitomycin-Induced Pulmonary Veno-Occlusive DiseaseCLINICAL PERSPECTIVE, Circulation, vol.132, issue.9, pp.834-881, 2015. ,
DOI : 10.1161/CIRCULATIONAHA.115.014207
Pulmonary Veno-Occlusive Disease, Medicine, vol.87, issue.4, pp.220-253, 2008. ,
DOI : 10.1097/MD.0b013e31818193bb
URL : https://hal.archives-ouvertes.fr/inserm-01436297
Pulmonary Veno-occlusive Disease, American Journal of Respiratory and Critical Care Medicine, vol.162, issue.5, pp.1964-73, 2000. ,
DOI : 10.1164/ajrccm.162.5.9912045
Massive Pulmonary Edema and Death After Prostacyclin Infusion in a Patient With Pulmonary Veno-occlusive Disease, Chest, vol.113, issue.1, pp.237-277, 1998. ,
DOI : 10.1378/chest.113.1.237
Updated Clinical Classification of Pulmonary Hypertension, Journal of the American College of Cardiology, vol.62, issue.25, pp.34-41, 2013. ,
DOI : 10.1016/j.jacc.2013.10.029
Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1461, 2004. ,
DOI : 10.1056/NEJMra040291
URL : https://hal.archives-ouvertes.fr/hal-01455600
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension, Circulation, vol.130, issue.24, pp.2189-208, 2014. ,
DOI : 10.1161/CIRCULATIONAHA.114.006974
Reference Equations for the Six-Minute Walk in Healthy Adults, American Journal of Respiratory and Critical Care Medicine, vol.158, issue.5, pp.1384-87, 1998. ,
DOI : 10.1164/ajrccm.158.5.9710086
A Proportional Hazards Model for the Subdistribution of a Competing Risk, Journal of the American Statistical Association, vol.69, issue.446, pp.496-509, 1999. ,
DOI : 10.2307/2530374
When do we need competing risks methods for survival analysis in nephrology?, Nephrology Dialysis Transplantation, vol.28, issue.11, pp.2670-77, 2013. ,
DOI : 10.1093/ndt/gft355
Competing risks in epidemiology: possibilities and pitfalls, International Journal of Epidemiology, vol.41, issue.3, pp.861-70, 2012. ,
DOI : 10.1093/ije/dyr213
Competing Risk Regression Models for Epidemiologic Data, American Journal of Epidemiology, vol.170, issue.2, pp.244-56, 2009. ,
DOI : 10.1093/aje/kwp107
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732996
CT of the Chest in Pulmonary Venoocclusive Disease, American Journal of Roentgenology, vol.183, issue.1, pp.65-70, 2004. ,
DOI : 10.2214/ajr.183.1.1830065
Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension, European Respiratory Journal, vol.43, issue.4, pp.1195-98, 2014. ,
DOI : 10.1183/09031936.00136413
Genetic counselling in a national referral centre for pulmonary hypertension, European Respiratory Journal, vol.47, issue.2, pp.541-52, 2015. ,
DOI : 10.1183/13993003.00717-2015
Safety and Efficacy of Epoprostenol Therapy in Pulmonary Veno-Occlusive Disease and Pulmonary Capillary Hemangiomatosis, Circulation Journal, vol.76, issue.7, pp.1729-1765, 2012. ,
DOI : 10.1253/circj.CJ-11-0973
Characteristics of Patients with Pulmonary Venoocclusive Disease Awaiting Transplantation, Annals of the American Thoracic Society, vol.11, issue.9, pp.1411-1429, 2014. ,
DOI : 10.1513/AnnalsATS.201408-354OC
Genetic analyses in a cohort of children with pulmonary hypertension, European Respiratory Journal, vol.48, issue.4, pp.1118-1144, 2016. ,
DOI : 10.1183/13993003.00211-2016